Sensitivity of tests to assess improvement in ADHD symptomatology

To assess which measurements best predict improvement on ADHD symptomatology after medication is given. 147 children aged 6 to 12 years, diagnosed with ADHD, participated in a double-blind placebo controlled twoweek crossover trial of methylphenidate. There were statistically significant differences...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Canadian child and adolescent psychiatry review 2004-05, Vol.13 (2), p.36-39
Hauptverfasser:	Grizenko, Natalie, Lachance, Martin, Collard, Vincent, Lageix, Philippe, Baron, Chantal, Ben Amor, Leila, Stepanian, Marina Ter, Mbekou, Valentin, Schwartz, George, Bellingham, Johanne, Joober, Ridha
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To assess which measurements best predict improvement on ADHD symptomatology after medication is given. 147 children aged 6 to 12 years, diagnosed with ADHD, participated in a double-blind placebo controlled twoweek crossover trial of methylphenidate. There were statistically significant differences on all measures between placebo and medication. Effect size for the overall group was 0.33 (CGI-P), 0.80 (CGI-T), 1.33 (CGI), 0.56 (CPT), 0.82 (RASS). Acute behavioural response measures, where children are observed by clinicians (RASS and CGI), were overall more reliable than parent reports in detecting improvement on ADHD symptomatology. Teacher reports were also very important, especially in the 9 to 12 year old group.
ISSN:	1716-9119